Copyright Reports & Markets. All rights reserved.

Global Non-opioid Pain Patches Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Non-opioid Pain Patches Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Non-opioid Pain Patches Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Non-opioid Pain Patches Market Size Growth Rate by Type
    • 1.4.2 Lidocaine Patch
    • 1.4.3 Diclofenac Patch
    • 1.4.4 Methyl Salicylate Patch
    • 1.4.5 Capsaicin Patch
    • 1.4.6 Ketoprofen Patch
    • 1.4.7 Other
  • 1.5 Market by Application
    • 1.5.1 Global Non-opioid Pain Patches Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Independent Pharmacies & Drug Stores
    • 1.5.4 Online Pharmacies
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Non-opioid Pain Patches Market Size, Estimates and Forecasts
    • 2.1.1 Global Non-opioid Pain Patches Revenue 2015-2026
    • 2.1.2 Global Non-opioid Pain Patches Sales 2015-2026
  • 2.2 Global Non-opioid Pain Patches, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Non-opioid Pain Patches Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Non-opioid Pain Patches Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Non-opioid Pain Patches Competitor Landscape by Players

  • 3.1 Non-opioid Pain Patches Sales by Manufacturers
    • 3.1.1 Non-opioid Pain Patches Sales by Manufacturers (2015-2020)
    • 3.1.2 Non-opioid Pain Patches Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Non-opioid Pain Patches Revenue by Manufacturers
    • 3.2.1 Non-opioid Pain Patches Revenue by Manufacturers (2015-2020)
    • 3.2.2 Non-opioid Pain Patches Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Non-opioid Pain Patches Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Non-opioid Pain Patches Revenue in 2019
    • 3.2.5 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Non-opioid Pain Patches Price by Manufacturers
  • 3.4 Non-opioid Pain Patches Manufacturing Base Distribution, Product Types
    • 3.4.1 Non-opioid Pain Patches Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Non-opioid Pain Patches Product Type
    • 3.4.3 Date of International Manufacturers Enter into Non-opioid Pain Patches Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Non-opioid Pain Patches Market Size by Type (2015-2020)
    • 4.1.1 Global Non-opioid Pain Patches Sales by Type (2015-2020)
    • 4.1.2 Global Non-opioid Pain Patches Revenue by Type (2015-2020)
    • 4.1.3 Non-opioid Pain Patches Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Non-opioid Pain Patches Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Non-opioid Pain Patches Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Non-opioid Pain Patches Revenue Forecast by Type (2021-2026)
    • 4.2.3 Non-opioid Pain Patches Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Non-opioid Pain Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Non-opioid Pain Patches Market Size by Application (2015-2020)
    • 5.1.1 Global Non-opioid Pain Patches Sales by Application (2015-2020)
    • 5.1.2 Global Non-opioid Pain Patches Revenue by Application (2015-2020)
    • 5.1.3 Non-opioid Pain Patches Price by Application (2015-2020)
  • 5.2 Non-opioid Pain Patches Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Non-opioid Pain Patches Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Non-opioid Pain Patches Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Non-opioid Pain Patches Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Non-opioid Pain Patches by Country
    • 6.1.1 North America Non-opioid Pain Patches Sales by Country
    • 6.1.2 North America Non-opioid Pain Patches Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Non-opioid Pain Patches Market Facts & Figures by Type
  • 6.3 North America Non-opioid Pain Patches Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Non-opioid Pain Patches by Country
    • 7.1.1 Europe Non-opioid Pain Patches Sales by Country
    • 7.1.2 Europe Non-opioid Pain Patches Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Non-opioid Pain Patches Market Facts & Figures by Type
  • 7.3 Europe Non-opioid Pain Patches Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Non-opioid Pain Patches by Region
    • 8.1.1 Asia Pacific Non-opioid Pain Patches Sales by Region
    • 8.1.2 Asia Pacific Non-opioid Pain Patches Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Type
  • 8.3 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Non-opioid Pain Patches by Country
    • 9.1.1 Latin America Non-opioid Pain Patches Sales by Country
    • 9.1.2 Latin America Non-opioid Pain Patches Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Non-opioid Pain Patches Market Facts & Figures by Type
  • 9.3 Central & South America Non-opioid Pain Patches Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Non-opioid Pain Patches by Country
    • 10.1.1 Middle East and Africa Non-opioid Pain Patches Sales by Country
    • 10.1.2 Middle East and Africa Non-opioid Pain Patches Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Type
  • 10.3 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Non-opioid Pain Patches Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Corporation Information
    • 11.2.2 GlaxoSmithKline Description and Business Overview
    • 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 GlaxoSmithKline Non-opioid Pain Patches Products Offered
    • 11.2.5 GlaxoSmithKline Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description and Business Overview
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Non-opioid Pain Patches Products Offered
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 Novartis AG
    • 11.4.1 Novartis AG Corporation Information
    • 11.4.2 Novartis AG Description and Business Overview
    • 11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis AG Non-opioid Pain Patches Products Offered
    • 11.4.5 Novartis AG Related Developments
  • 11.5 Mylan N.V.
    • 11.5.1 Mylan N.V. Corporation Information
    • 11.5.2 Mylan N.V. Description and Business Overview
    • 11.5.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan N.V. Non-opioid Pain Patches Products Offered
    • 11.5.5 Mylan N.V. Related Developments
  • 11.6 Teva Pharmaceutical Industries
    • 11.6.1 Teva Pharmaceutical Industries Corporation Information
    • 11.6.2 Teva Pharmaceutical Industries Description and Business Overview
    • 11.6.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Products Offered
    • 11.6.5 Teva Pharmaceutical Industries Related Developments
  • 11.7 Hisamitsu Pharmaceutical
    • 11.7.1 Hisamitsu Pharmaceutical Corporation Information
    • 11.7.2 Hisamitsu Pharmaceutical Description and Business Overview
    • 11.7.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Products Offered
    • 11.7.5 Hisamitsu Pharmaceutical Related Developments
  • 11.8 TEH SENG Pharmaceutical
    • 11.8.1 TEH SENG Pharmaceutical Corporation Information
    • 11.8.2 TEH SENG Pharmaceutical Description and Business Overview
    • 11.8.3 TEH SENG Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Products Offered
    • 11.8.5 TEH SENG Pharmaceutical Related Developments
  • 11.9 Teikoku Seiyaku
    • 11.9.1 Teikoku Seiyaku Corporation Information
    • 11.9.2 Teikoku Seiyaku Description and Business Overview
    • 11.9.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Teikoku Seiyaku Non-opioid Pain Patches Products Offered
    • 11.9.5 Teikoku Seiyaku Related Developments
  • 11.10 IBSA Institut Biochimque SA
    • 11.10.1 IBSA Institut Biochimque SA Corporation Information
    • 11.10.2 IBSA Institut Biochimque SA Description and Business Overview
    • 11.10.3 IBSA Institut Biochimque SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Products Offered
    • 11.10.5 IBSA Institut Biochimque SA Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Non-opioid Pain Patches Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.12 Allergan PLC
    • 11.12.1 Allergan PLC Corporation Information
    • 11.12.2 Allergan PLC Description and Business Overview
    • 11.12.3 Allergan PLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Allergan PLC Products Offered
    • 11.12.5 Allergan PLC Related Developments
  • 11.13 Endo International
    • 11.13.1 Endo International Corporation Information
    • 11.13.2 Endo International Description and Business Overview
    • 11.13.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Endo International Products Offered
    • 11.13.5 Endo International Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Non-opioid Pain Patches Market Estimates and Projections by Region
    • 12.1.1 Global Non-opioid Pain Patches Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Non-opioid Pain Patches Revenue Forecast by Regions 2021-2026
  • 12.2 North America Non-opioid Pain Patches Market Size Forecast (2021-2026)
    • 12.2.1 North America: Non-opioid Pain Patches Sales Forecast (2021-2026)
    • 12.2.2 North America: Non-opioid Pain Patches Revenue Forecast (2021-2026)
    • 12.2.3 North America: Non-opioid Pain Patches Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Non-opioid Pain Patches Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Non-opioid Pain Patches Sales Forecast (2021-2026)
    • 12.3.2 Europe: Non-opioid Pain Patches Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Non-opioid Pain Patches Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Non-opioid Pain Patches Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Non-opioid Pain Patches Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Non-opioid Pain Patches Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Non-opioid Pain Patches Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Non-opioid Pain Patches Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Non-opioid Pain Patches Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Non-opioid Pain Patches Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Non-opioid Pain Patches Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Non-opioid Pain Patches Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Non-opioid Pain Patches Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Non-opioid Pain Patches Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Non-opioid Pain Patches Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Non-opioid Pain Patches Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Non-opioid Pain Patches Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Non-opioid Pain Patches market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Non-opioid Pain Patches market is segmented into
    Lidocaine Patch
    Diclofenac Patch
    Methyl Salicylate Patch
    Capsaicin Patch
    Ketoprofen Patch
    Other

    Segment by Application, the Non-opioid Pain Patches market is segmented into
    Hospital Pharmacies
    Independent Pharmacies & Drug Stores
    Online Pharmacies

    Regional and Country-level Analysis
    The Non-opioid Pain Patches market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Non-opioid Pain Patches market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Non-opioid Pain Patches Market Share Analysis
    Non-opioid Pain Patches market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-opioid Pain Patches business, the date to enter into the Non-opioid Pain Patches market, Non-opioid Pain Patches product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    GlaxoSmithKline
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Hisamitsu Pharmaceutical
    TEH SENG Pharmaceutical
    Teikoku Seiyaku
    IBSA Institut Biochimque SA
    Acorda Therapeutics
    Allergan PLC
    Endo International

    Buy now